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Targeting the Function of Mature
Dendritic Cells by Human Cytomegalovirus:
A Multilayered Viral Defense Strategy
cytomegalovirus (Reddehase et al., 1985). In addition,
the importance of CTL for the protection from HCMV
disease has been elucidated in patients by adoptive
transfer of HCMV-specific CD8 T lymphocytes after
bone marrow transplantation (Greenberg and Riddell,
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developed delicate immune evasion mechanisms to per-10117 Berlin
sist and replicate even in a fully primed host (Ward and2 Institute of Hygiene
Roizman, 1998). In many cases these immune evasionDepartment of Medical Virology
mechanisms aim at downregulation of membrane pro-3 Institute of Immunology
teins of the major histocompatibility complex (MHC),University of Heidelberg
which present antigen-derived peptides to the T cell69120 Heidelberg
receptor (TCR) (Tortorella et al., 2000; Alcami and Koszi-4 Tumor Immunology Program
nowski, 2000). In this way, the number of target struc-Department of Apoptosis Regulation
tures for CTL and, hence, lysis of HCMV-infected cellsGerman Cancer Research Center (DKFZ)
could be reduced.69120 Heidelberg
As a more aggressive strategy, viruses can disableGermany
the host immune defense by attacking and manipulating
exactly those cells that play a pivotal role in the adaptive
immune response. The ensuing dysfunction or destruc-Summary
tion of immune cells leads to generalized or more local-
ized immunosuppression. For example, Herpes simplexHuman cytomegalovirus (HCMV) can suppress and
virus type 1 (HSV1) can infect activated T lymphocytesevade the immune system. We have identified as a
and induce fratricide, although it mainly propagates inmechanism the ability of HCMV to infect dendritic cells
epithelial cells (Raftery et al., 1999). Antigen-presenting(DC), which initiate the antiviral immune response.
cells (APC) that are derived from monocytes could beHCMV-infected DC show enhanced expression of co-
equally important targets of viral counterattacks. Mono-stimulatory molecules. In contrast, MHC molecules
cytes circulating in the blood respond to infection byare partially downregulated, leading to a reduced anti-
crossing the endothelial cell barrier, infiltrating the focusgen-presenting capacity. Moreover, the apoptosis-
of inflammation, and developing into either macrophagesinducing ligands CD95L (FasL) and tumor necrosis fac-
or dendritic cells (DC). Immature DC capture antigen andtor (TNF)-related apoptosis-inducing ligand (TRAIL)
process these antigens to form MHC-peptide com-are upregulated, thereby enabling HCMV-infected DC
plexes. En route to the draining lymphoid organs, theyto delete activated T lymphocytes. This additional layer
mature, thereby acquiring a characteristic pattern ofof viral defense is complemented by nondeletional
surface molecules that makes mature DC the most po-mechanisms, which suppress surviving T cells. Thus,
tent professional APC (Steinman, 1991; Banchereau andinfection of DC allows the virus to blunt the antiviral
Steinman, 1998). Mature DC efficiently activate naive/T cell response by a multilayered defense strategy and
resting T lymphocytes which subsequently develop intocould play a pivotal role in HCMV-triggered immuno-
cytokine-secreting helper T lymphocytes as well as CTL.suppression.
Finally, these effector T cells enter the site of infection
to eliminate virus-infected cells. Thus, it is evident that
Introduction
interactions of viruses with DC are crucial for the out-
come of viral infections (Bhardwaj, 1997).
Human cytomegalovirus (HCMV), which belongs to the Some DC-tropic viruses (e.g., influenza virus) seem-
subgroup of -herpesviruses, is an important human ingly leave DC function intact (Bhardwaj et al., 1994).
pathogen and is endemic throughout the world (Britt However, other DC-tropic viruses such as HIV (Maca-
and Alford, 1996). After primary infection, HCMV persists tonia et al., 1992; Blauvelt et al., 1995), measles virus
lifelong in the host organism. It becomes latent in my- (MV) (Grosjean et al., 1997; Fugier-Vivier et al., 1997;
eloid and dendritic cell progenitors (Hahn et al., 1998) Schnorr et al., 1997), lymphocytic choriomeningitis virus
and in monocytes/macrophages (Soderberg-Naucler et (LCMV) (Sevilla et al., 2000), and HSV1 (Kruse et al.,
al., 1997) from where it can reactivate. In patients with 2000) have evolved means to impair the function of DC,
an immature (i.e., fetus) or compromised (e.g., transplant thereby enhancing their chance to persist and escape
or AIDS patients) immune defense, HCMV infection can immuno surveillance. HCMV is an important human
result in severe and sometimes fatal disease involving pathogen that has long been known to induce or en-
organs like the liver, CNS, eye, gastrointestinal tract, hance immunosuppression in patients (Griffiths and
and lung. Grundy, 1987). The HCMV-associated defect in the cel-
For control of virus spread, CD8-cytotoxic T cells lular immune response has been attributed to alterations
(CTL) are crucial, as shown in mice infected with murine in the function of T lymphocytes (Southern and Old-
stone, 1986) or APC (Sissons, 1986). However, the pre-
cise molecular mechanism by which HCMV alters the5 Correspondence: guenther.schoenrich@charite.de
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Figure 1. HCMV Propagated in Endothelial Cells Infect Monocyte-Derived APC, Including DC
Detection of viral proteins by fluorescence microscopic analysis at day 5 after infection in vitro (MOI 5) with HCMV propagated in endothelial
cells (A–C). Infected multinuclear giant cells were incubated for 4 hr with latex beads (blue) before fixation and HCMV IE (FITC, green)
Immunosuppression Mediated by Human Cytomegalovirus
999
host immune response is a longstanding enigma and in cultures with virus-infected immature DC was reduced
to 14%, whereas 40% of HCMV-infected mature DCremains to be defined. In this report, we show that HCMV
infects mature DC and describe the phenotypic and survived (Figure 1G). This difference is explained by the
comparatively high level of apoptosis (23%) of immaturefunctional consequences thereof. Intriguingly, in addi-
tion to downregulation of MHC class I and II molecules, DC early after infection (Figure 1H). Moreover, a signifi-
cant proportion of infected cells become necrotic, pro-we observed that HCMV induces the functional expres-
sion of CD95 (Apo-1, Fas) ligand (CD95L) and tumor viding a strong maturation stimulus. In line with this
finding, we observed that immature DC surviving HCMVnecrosis factor (TNF)-related apoptosis-inducing ligand
(TRAIL), two apoptosis-inducing members of the TNF infection rapidly matured. This process was accompa-
nied by phenotypic changes, such as CD1a downregula-family (Green and Ware, 1997; Locksley et al., 2001).
This enables DC to kill activated T cells by induction of tion, upregulation of costimulatory molecules, and down-
regulation of MHC molecules (data not shown). Takenapoptosis. Moreover, proliferation of activated T lym-
phocytes that were not deleted was reduced. Thus, in- together these experiments verified that DC support
nonlytic HCMV infection with the virus remaining primar-fection of mature DC makes it possible for HCMV to
subvert the antiviral T cell response by a multilayered ily cell associated.
strategy involving downregulation of MHC molecules
and T cell suppression by deletional as well as nondele- HCMV Alters the Expression of Functionally
tional mechanisms. Important Molecules on Mature DC
Among monocyte-derived cells, mature DC are consid-
ered the most potent APC and accordingly play a pivotalResults
role in initiating the adaptive immune response against
viruses. To fulfill their function, mature DC have to effi-HCMV Infects Monocyte-Derived APC, Including DC
Whether virus infections elicit an efficient antiviral im- ciently express MHC molecules on the cell surface and
provide signals through costimulatory molecules. HCMVmune response critically depends on the function of
professional APC. These immune cells, therefore, can could perturb expression of these functionally important
molecules. Therefore, we examined the phenotype ofbe targets of prime importance for viral immune evasion
mechanisms. In the search for monocyte-derived APC HCMV-infected mature DC. As depicted in Figure 2A,
they retained the surface expression of typical markertargeted by HCMV, we analyzed the susceptibility of
macrophages, multinuclear giant cells, and DC to HCMV molecules like CD4, CD11b, and CD83. The expression
of adhesion molecule CD58 (LFA-3) and the absence ofinfection. Established fibroblast-adapted strains of HCMV
such as AD169 or Davis were unable to infect these other marker molecules like CD8 and CD14 were also not
affected (data not shown). In contrast, the costimulatorycell types. However, after infection with recent HCMV
isolates propagated on endothelial cells, we could de- molecules CD40, CD80, and CD86 were slightly upregu-
lated after infection. Infected mature DC were alsotect immediate early (IE) and late (pp65, p22) viral pro-
teins in all these monocyte-derived APC. Examples of shown to be highly activated by enhanced expression
of the activation marker CD25. Intriguingly, we foundthis type of analysis are given in Figures 1A–1C. More-
over, monocyte-derived DC were generated from PBMC that both MHC class I and II molecules were significantly
downregulated after HCMV infection. These changesthat have been isolated from immunosuppressed pa-
tients with a highly active HCMV infection (more than in expression of surface molecules could have been
induced by cytokines released during infection. To test100 pp65-positive cells in 5 105 leukocytes) after organ
transplantation. At the immature stage, these DC showed this possibility we incubated uninfected mature DC with
virus-free supernatant from infected mature DC or exog-no evidence of active infection. However, after inducing
DC maturation, cell-associated virus could be isolated enous IL-10. Phenotypic changes did not occur, exclud-
ing changes in cytokine expression as the cause of thewithout exposure to HCMV in vitro, and viral IE protein
could be detected by flourescence microscopic analysis reduced expression of MHC antigens (data not shown).
This was verified by experiments in which HCMV-(Figure 1D). The ability of DC to be infected in vitro was
assessed in more detail. Cultures with HCMV-infected infected mature DC were double stained for MHC class
II molecules and nuclear viral IE proteins at day 5 postin-DC did not release infectious particles into the superna-
tant after day 5 postinfection when compared to HCMV- fection (Figure 2B). FACS analysis revealed that in
HCMV-infected cultures, the IE-positive cell populationinfected endothelial cell cultures (Figure 1E). Neverthe-
less, HCMV replicated in DC because it could be detected (25%) showed a decreased surface expression when
compared to the IE-negative population (mean 104 andas cell-associated virus throughout day 13 postinfection
(Figure 1F). At this time point the percentage of live cells 197, respectively). In addition, confocal microscopy
staining (A). Infected mature DC were stained with monoclonal antibodies (FITC, green) specific for HCMV IE (B) or late protein pp22 (C) and
counterstained with evans blue (red). The yellow color results from colocalization of red and green fluoresence. Detection of viral IE protein
(FITC, green) by fluorescence microscopic analysis in mature DC generated from PBMC of immunosuppressed patients with highly active
HCMV infection after organ transplantation (D). The white scale bars in the lower right corner represent 40 m. Level of infectious virus in the
supernatant of cultures with mature DC (mDC), immature DC (iDC), and human umbilical endothelial cells (HUVEC) over 13 days after HCMV
infection (E). Level of cell-associated virions in cultures of mDC and iDC after infection (F). Percentage of surviving cells as determined by
trypan blue exclusion assay at day 13 postinfection (G). Level of apoptosis (percentage of annexin-V-positive cells) and necrosis (percentage
of PI-positive cells) at day 3 postinfection (H). DC were incubated with heat-inactivated virus (mock infected) as a control (G and H).
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confirmed that mature DC with the strongest MHC class their expansion as a hint for a deletional mechanism.
Consequently, we analyzed the cytotoxic activity ofII downregulation were IE-positive. The surface expres-
sion of MHC class I molecules was also tested by double HCMV-infected mature DC by quantifying DNA fragmen-
tation in apoptotic target cells. For this purpose we uti-staining and was found to be reduced on virus-infected
mature DC (data not shown). We assume, therefore, that lized as targets either the T cell line Jurkat or autologous
PBMC activated for 3 days with PHA (Figure 4A). Weviral proteins directly influence surface expression of
MHC molecules that are crucial for the extraordinary found that HCMV-infected mature DC were more than
twice as cytotoxic as uninfected or mock-infected ma-antigen-presenting capacity of mature DC.
ture DC. To further analyze the molecular events leading
to enhanced killing by HCMV-infected mature DC, weHCMV-Infected DC Efficiently Suppress
T Cells by Mechanisms Other Than investigated expression of apoptosis-inducing mem-
bers of the TNF cytokine family on the surface of theseT Cell Exhaustion or Ignorance
We examined the functional consequences of the phe- cells. FACS analysis revealed that HCMV infection in-
duces expression of CD95L (FasL) and TRAIL but notnotypic changes that occurred after HCMV infection of
DC. For this purpose we employed an allogeneic mixed of the membrane form of TNF- (Figure 4B). We then
examined to what extent the death ligands contributelymphocyte reaction (MLR) (Figure 3A). The proliferative
T cell response was drastically reduced (up to 85%) to the killing of T cells by HCMV-infected mature DC. For
this purpose we blocked the activity of the respectiveafter stimulation for 5 days with HCMV-infected DC. This
effect could have been due to a shift in kinetics with a ligands with chimeric receptor-Fc fusion proteins (Fig-
ure 4C). The cytotoxity of HCMV-infected DC againstproliferation peak at an earlier time point immediately
followed by T cell exhaustion. However, analysis over activated autologous PBMC could be blocked by chime-
ric CD95-Fc protein. In addition, chimeric TRAIL recep-time revealed that this was not the case: no significant
T cell proliferation with HCMV-infected DC as stimula- tor 2 (TRAIL-R2)-Fc could prevent apoptosis induction,
whereas blocking of TNF- with TNF-R2-Fc had little ortors was observed at any time point up to day 5 (Figure
3B). As a possible explanation, T lymphocytes could no effect. Interestingly though, in the absence of HCMV-
infected mature DC, apoptosis of activated T cells couldhave simply ignored HCMV-infected DC because HCMV
partially downregulates MHC molecules. In order to test not be induced by agonistic anti-CD95 antibody or
TRAIL itself. Taken together, these results imply thatthis hypothesis, PBMC from HCMV-seropositive donors
were incubated with HCMV-infected mature autologous mature DC become killer cells by the combined action
DC, and the frequency of HCMV-reactive IFN--produc- of two HCMV-induced mechanisms: HCMV-infected DC
ing CD8 T cells was determined. Figure 3C shows that render activated T cells susceptible to apoptosis signal-
these responder cells could be found at a frequency ing by an unknown mechanism and upregulate death
within the expected range after 6 hr, whereas incubation ligands, which then trigger deletion of the activated and
of PBMC from the same donor with uninfected or mock- sensitized T cells.
infected mature DC did not yield IFN--producing T lym-
phocytes. In contrast, similar experiments performed
HCMV-Induced Killer DC Blunt the Antiviralwith PBMC from HCMV-seronegative donors detected no
T Cell Responsesignificant numbers of IFN--producing T cells. Moreover,
In the next series of experiments, we investigatedwe observed an increased percentage of CD3 cells
whether HCMV-induced killer DC could blunt the antiviralexpressing the activation marker CD69 after stimulation
T cell response. For this purpose HCMV-reactive CD4with HCMV-infected autologous mature DC (Figure 3D).
and CD8 T cell lines were employed. These preacti-Thus, HCMV-infected DC could specifically activate T lym-
vated T lymphocytes were incubated with autologousphocytes despite partial downregulation of MHC mole-
mature DC that had been infected with the endothelialcules. Taken together, these findings indicate that HCMV-
cell-adapted strain (Figure 5A). A high percentage ofinfected mature DC actively suppress T cell proliferation
cells in both T cell subpopulations underwent apoptosisby means other than T cell exhaustion or ignorance.
in the presence of these HCMV-infected mature DC,
whereas the rate of cell death was much lower when T cellHCMV-Infected Mature DC Become Killer Cells
lines were cocultured with mock-infected mature DC.We took the observation that HCMV-infected DC can
activate T lymphocytes and at the same time prevent In addition, we examined the response of T cells from
Figure 2. HCMV Modulates Expression of Functionally Important Surface Molecules on Mature DC
At day 5 postinfection (MOI 5) monocyte-derived mature dendritic were harvested and stained for markers as indicated.
(A) FACS histograms of surface expression. The black curves represent expression of the corresponding marker molecules on HCMV-infected
DC, whereas gray curves show surface expression on DC infected with heat-inactivated virus (mock infected). The gray filled-in curves depict
staining of HCMV-infected mature DC with an irrelevant antibody (isotype control). On the x axis, the fluorescence intensity (log scale, 4
decades) is given, whereas the y axis depicts the relative cell number.
(B) Double staining for MHC II molecules and intranuclear viral IE proteins in mock-infected (left side) and HCMV-infected (right side) cultures
of mature DC. FACS analysis (upper row): the x axis represents MHC II staining, whereas the y axis depicts intranuclear IE staining. In cultures
with HCMV-infected mature DC, 25% were IE positive and showed a decreased surface expression of MHC class II molecules (mean of IE-
positive cells, 104; mean of IE-negative cells, 197). Confocal microscopy analysis: viral IE protein was detected with an FITC-labeled antibody
(green), whereas MHC class II molecules were stained with a Texas red-coupled reagent (red). The white scale bars in the lower right corner
represent 10 m. The results shown are representative for three independent experiments.
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Figure 3. Infected Mature DC Suppress T Cell Proliferation but Retain the Capacity to Activate T Cells
(A) Suppression of T cell proliferation 5 days after stimulation with HCMV-infected mature DC (mDC). HCMV-infected mDC were irradiated
and used as stimulator cells for allogeneic T cells at various T cell:mDC ratios (x axis). As a control, mDC incubated with heat-inactivated
HCMV (mock infected) were used in the same way. Proliferation was determined in counts per minute (cpm with SD) after [3H]thymidine
incorporation (y axis).
(B) HCMV-mediated suppression of T cell proliferation is not due to T cell exhaustion. HCMV-infected or mock-infected allogeneic mature
DC were irradiated and used as stimulator cells for T cells at various T cell:mDC ratios in a mixed lymphocyte reaction (MLR). Proliferation
over time was determined in cpm after [3H]thymidine incorporation 1–5 days after initiation of MLR.
(C) Percentage of HCMV-reactive IFN--producing CD8 T cells from an HCMV-seropositive donor after stimulation for 6 hr with uninfected,
mock-infected, or HCMV-infected autologous mature DC (only CD8 cells were included in the live gate of the cytofluorimetric analysis). As
a control, CD8 T lymphocytes from an HCMV-seronegative donor were analyzed in the same way.
(D) Percentage of CD3 T lymphocytes expressing the activation marker CD69 after incubation for 3 days with uninfected, mock-infected, or
HCMV-infected autologous mature DC. In all experiments, DC were used after maturation in 33% MCM. Data shown are representative for
three independent experiments.
seropositive donors to HCMV-infected mature DC. As exclude other mechanisms contributing to HCMV-medi-
ated T cell suppression. In fact, a significant number ofshown in Figure 5B, significant induction of apoptosis
occurred in T cell populations that had been activated activated T cells survived contact with death ligand-
expressing HCMV-infected mature DC. Intriguingly,with autologous HCMV-infected mature DC. In contrast,
no significant numbers of apoptotic CD3 cells were these surviving cells showed suppressed proliferation
after secondary stimulation in the absence of virus (Fig-detected after incubation with uninfected or mock-
infected mature DC. We then investigated which mem- ure 6A). This result suggested that nondeletional mecha-
bers of the TNF cytokine family were responsible for nisms could complement induction of apoptosis in T cell
induction of apoptosis by blocking the interaction of suppression mediated by HCMV-infected DC. To dem-
death ligands with their respective receptors. As found onstrate this, we used experimental systems in which
for the killing of PHA-activated T lymphocytes, blocking death ligand-induced apoptosis was not relevant (Figure
of CD95L or TRAIL strongly reduced induction of apo- 6B). First we incubated wild-type human Jurkat T cells
ptosis, whereas blocking of TNF was less effective (Fig- with virus-infected mature DC at a low effector:target
ure 5C). Thus, HCMV-infected DC blunt the antiviral T (ET) ratio, which allows only residual death ligand-medi-
cell response by induction of apoptosis via CD95L and ated T cell deletion (ET ratio 0.2, see Figure 4A). As
TRAIL. shown in Figure 6B (left side), proliferation of wild-type
Jurkat T cells at this ratio was significantly reduced
despite only background levels of apoptosis induction.Nondeletional Mechanisms Contribute to T Cell
Suppression Mediated by HCMV-Infected DC In order to exclude any death ligand-induced T cell apo-
ptosis and to verify our finding with wild-type JurkatThe observation that HCMV-infected mature DC in-
duced apoptosis in activated T lymphocytes did not T cells, we employed a caspase-8-deficient Jurkat T
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Figure 4. HCMV-Infected DC Kill Polyclonally Activated T Cells Due to Upregulation of CD95L and TRAIL Molecules
(A) To test their T cell killing capacity, HCMV-infected mature DC (mDC) were incubated with Jurkat (left graph) or polyclonally activated
autologous PBMC (right graph) as target cells. mDC incubated with heat-inactivated virus (mock-infected) and uninfected mDC were employed
as control effector cells. For quantification of cell death, a 7 hr JAM assay was used. The x axis gives the various Effector:Target (ET) ratios,
and the y axis indicates the percentage of DNA fragmentation with SD.
(B) FACS analysis of death ligand expression (CD95L, TRAIL, and membrane bound TNF-) on mock-infected (black filled-in curve) and HCMV-
infected (unfilled curve) mDC. The x axis shows fluorescence intensity (log scale), and the y axis depicts the relative cell number.
(C) HCMV-infected mDC were used as effector cells to kill polyclonally activated autologous PBMC (ET ratio 2.5) in JAM tests using chimeric
Fc-human CD95 to block CD95L, chimeric Fc-human TRAILR2 to block TRAIL, and chimeric Fc-TNFR2 to block TNF. In addition, PBMC
polyclonally activated for 3 days were incubated with agonistic anti-CD95 antibody or TRAIL to mimic CD95 and TRAIL receptor ligation in
the absence of HCMV-infected mature DC. In these experiments, DC were employed after maturation in 33% MCM. All experiments were
performed three times with comparable results.
lymphocyte cell line (Juo et al., 1998). Similarly to wild- eliminated after incubation with HCMV-infected DC are
subject to nondeletional control mechanisms.type Jurkat T cells, proliferation of caspase-8-negative
Jurkat T lymphocytes was decreased in the presence of Taken together, our findings support the concept that
mature DC represent immunologically important targetsHCMV-infected mature DC (Figure 6B, right side). These
analyses demonstrate that activated T cells that are not for HCMV and allow the virus to establish a multilayered
Immunity
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Figure 5. Antiviral T Cells Become Apoptotic
Due to Signals through CD95 and TRAIL after
Stimulation with HCMV-Infected DC
(A) Levels of apoptosis after 3 days of incuba-
tion of CD4 and CD8 HCMV-reactive T cell
lines with HCMV-infected mature DC. Mature
DC exposed to heat-inactivated HCMV (mock
infected) were used as a control.
(B) T cells isolated from an HCMV-sero-
positive donor were incubated for 3 days
with uninfected, mock-infected, or HCMV-
infected autologous mDC, and the percent-
age of apoptotic cells was determined.
(C) T cells isolated from an HCMV-seroposi-
tive donor were incubated for 3 days with
HCMV-infected autologous mDC. The reduc-
tion of apoptosis in the presence of chimeric
CD95-Fc to block CD95L, TRAIL-R2-Fc to
block TRAIL, and TNF-R2-Fc to block TNF
was measured. In all experiments, DC were
used after maturation in 33% MCM. These
experiments were done twice with compara-
ble results.
defense strategy against T cells. This includes downreg- et al., 1996; Ahn et al., 1996, 1997; Hengel et al., 1997).
Such mechanisms could blunt the generation of antiviralulation of MHC molecules and suppression of activated
T lymphocytes by deletional as well as nondeletional CD8 T lymphocytes by infected DC, thereby weakening
the host defense.mechanisms.
In comparison to the viral effect on MHC class I ex-
pression, we found a less pronounced albeit significantDiscussion
downregulation of MHC class II molecules by HCMV-
infected mature DC. The reduction of MHC class II ex-In previous studies the defense strategies of HCMV have
been investigated using established strains adapted to pression on the surface was not due to soluble factors
for several reasons. First, cultivating mature DC in virus-fibroblasts, which are not an essential part of the host’s
immune system. Thus, the physiological relevance of free supernatant from infected mature DC or in cell cul-
ture medium containing IL-10 did not cause phenotypicthese findings and the target cells of viral counterattacks
in vivo remain to be defined. Therefore, we analyzed changes (data not shown). Second, a recent report dem-
onstrated that, in general, mature DC are resistant towhether HCMV can infect monocyte-derived cells in par-
ticular mature DC, which are known to play a pivotal role the effect of cytokines (Kalinski et al., 1999). Supporting
this view, double-staining experiments clearly showedin initiating the antiviral T cell responses, and studied the
phenotypic and functional consequences thereof. that mature DC with reduced surface expression of MHC
class II molecules were IE positive. This suggests thatWe observed that DC can be productively infected
with HCMV isolates propagated in endothelial cell cul- viral proteins inside the cell directly trigger the pheno-
typic changes. By analyzing virus-infected, transformedtures, but not with established fibroblast-adapted HCMV
strains such as AD169 or Davis. The virus remained glioblastoma cells, so far only 1 HCMV protein (US2)
has been implicated in downregulation of MHC classprimarily cell associated and did not lyse the cells. In-
triguingly, HCMV-infected DC displayed a characteris- II expression (Tomazin et al., 1999). Thus, fewer viral
proteins could be involved in blocking antigen presenta-tic abnormal phenotype. Marker molecules like CD4,
CD11b, and CD83 were expressed in a stable fashion, tion through the MHC class II pathway, making it less
efficient than MHC class I downregulation. On the otherwhereas expression of costimulatory molecules (CD40,
CD80, and CD86) was slightly enhanced. Our report hand, this quantitative difference could also be due to
the high stability of peptide class II complexes on thedemonstrates HCMV-mediated downregulation of both
MHC class I and II molecules on the most potent antigen- cell surface in comparison to the rapid turnover of MHC
class I molecules (Cella et al., 1997). The generation ofpresenting cells of the immune system. Downregulation
of MHC class I molecules by HCMV was first discovered MHC class II ligands is an important means for DC to
control immunity (Inaba et al., 2000), and HCMV-medi-in fibroblasts and is the consequence of at least four
viral proteins that counteract antigen presentation by ated inhibition of this process may weaken the antiviral
immune response. Since signals via MHC class II mole-distinct mechanisms (Wiertz et al., 1996a, 1996b; Jones
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cules lead to the demise of mature DC (Bertho et al.,
2000), such a viral counterattack may also directly help
HCMV-infected DC to survive.
The incomplete downregulation of MHC molecules
did not explain the profound HCMV-associated T cell
suppression that we observed in functional tests. Unin-
fected DC express 10–100 times higher levels of MHC
molecules than other APC like monocytes and B lym-
phocytes (Inaba et al., 1997). As a consequence, there
are still comparably high levels of MHC-peptide com-
plexes on virus-infected DC despite partial downregula-
tion of MHC molecules. Second, even scarce numbers
of TCR ligands on DC (i.e., 100–1000 copies/cell) are
effective for T cell stimulation (Bhardwaj et al., 1993).
Moreover, the observed increase in expression of CD80,
CD86, and CD40 on DC after HCMV infection constitutes
a strong costimulatory “signal 2.” This could at least in
part compensate for the reduced number of TCR ligands
(“signal 1”) (Viola and Lanzavecchia, 1996). In fact,
HCMV-infected DC could activate T lymphocytes as
measured by the production of IFN- and the expression
of T cell activation markers like CD69.
As a novel mechanism underlying HCMV-associated
immunosuppression, we found that HCMV converts DC
into killer cells. These could eliminate Jurkat T cells
and activated PBMC by induction of apoptosis. Further
analysis revealed upregulation of the death ligands
CD95L and TRAIL on infected DC, which were responsi-
ble for the deletion of activated T cells as demonstrated
by blocking experiments. In a recent report, it has been
shown that HCMV directly upregulates TRAIL on virus-
infected fibroblasts and that this effect is potentiated
by IFN- (Sedger et al., 1999). Furthermore, uninfected
human DC that express TRAIL after activation with either
IFN- or - were found to kill Jurkat T cells via TRAIL
(Fanger et al., 1999). So far TRAIL by itself was thought
to induce apoptosis primarily in transformed cell lines
but not in normal cells (Wiley et al., 1995; Pitti et al., 1996;
Walczak et al., 1999; Ashkenazi et al., 1999), although
human thymocytes have been proven recently to be
susceptible to TRAIL-mediated apoptosis (Simon et al.,
2001). Supporting this view, we found that TRAIL by
itself did not induce apoptosis of activated T cells in
the absence of HCMV-infected DC. On the other hand,
blocking of TRAIL abrogated apoptosis of normal T cells
triggered by HCMV-infected DC. Interestingly, a similar
observation has been made in severe combined immu-
nodeficient (SCID) mice reconstituted with human pe-
ripheral blood lymphocytes and infected with HIV-1 (Mi-
ura et al., 2001). In accordance with this finding, T cellsFigure 6. HCMV-Infected Mature DC Suppress T Cell Proliferation
by Nondeletional Mechanisms from HIV-1-infected patients show increased CD95 sen-
sitivity and enhanced susceptibility to TRAIL-induced(A) Suppression of T cells surving contact with death ligand-express-
ing HCMV-infected mature DC. For primary stimulation a starting cell death (Jeremias et al., 1998). Taken together, these
population of 3  106 autologous T cells were incubated for 3 days results indicate that immunosuppressive viruses may
with heat-inactivated (mock-infected) or HCMV-infected, irradiated generate killer DC, which sensitize T lymphocytes for
mDC in the presence of a polyclonal stimulus (PHA). After 10 days,
the surviving populations of T cells were isolated by ficoll and
counted. The total numbers of surviving lymphocytes were 6.2 
106 versus 3  106. Equal numbers (105 per well) of surviving lympho-
infected (black bars) mDC (mDC: T cell ratio 0.25). After 3 days,cytes were restimulated with PHA in the absence of virus. Proliferation
was measured 3 days later in cpm after [3H]thymidine incorporation. proliferation was determined in cpm after [3H]thymidine incorpora-
tion. Tests were carried out in triplicate, and results are expressed(B) HCMV-infected mature DC suppress proliferation of Jurkat T
lymphocytes not deleted by death ligand-induced apoptosis. Wild- as mean cpm with SD. In all experiments, DC were employed after
maturation in 33% MCM. The results shown are representative fortype Jurkat T cells and Jurkat T lymphocytes deficient in caspase-8
were incubated with either mock-infected (white bars) or HCMV- three independent experiments.
Immunity
1006
Figure 7. Targeting the Function of Mature
DC by HCMV: A Model of a Multilayered Viral
Defense Strategy
Viral proteins partially downregulate MHC
molecules on mature DC. However, some
resting (r) antviral T cells can pass this 1 layer
of viral defense and are activated. Therefore,
a 2 layer of viral defense prevents expansion
of activated (a) T lymphocytes by deletional
(CD95L- and TRAIL-mediated) and nondele-
tional T cell-suppression. Only a few cells
pass this second bottleneck and become ef-
fector (e) T lymphocytes. Irrespective of the
antigen specificity, any activated T cell within
the vicinity of HCMV-infected mature DC will
be subject to the 2 layer of viral defense.
This may explain the clinical observation of
increased susceptibility to other infections in
the course of HCMV infection in vivo.
Experimental Procedurescell death and concomitantly induce apoptosis via
TRAIL and CD95L.
Media and Recombinant CytokinesIn addition to deletion, we found that HCMV-infected
Human monocytes and lymphocytes were maintained in RP medium
DC suppress proliferation of activated T lymphocytes consisting of RPMI 1640 supplemented with 10% heat-inactivated
by nondeletional mechanisms. Jurkat T lymphocytes de- FCS, 100 IU penicillin, 100 g/ml streptomycin, 4.5 mM glutamine,
and 10 mM HEPES. Human embryonic lung fibroblasts (HEL) wereficient in caspase-8 (Juo et al., 1998) and, therefore,
maintained in DM medium consisting of DMEM with 10% FCS, 100resistant to death signaling by CD95L and TRAIL did
IU penicillin, 100 g/ml streptomycin, and 4.5 mM L-glutamine. Hu-not proliferate in the presence of HCMV-infected mature
man umbilical vein endothelial cells (HUVEC) were grown in RP-HuDC. Moreover, T cells surviving contact with virus-
medium consisting of RPMI 1640 supplemented with 20% heat-
infected killer DC did not proliferate after polyclonal re- inactivated FCS, 100 IU penicillin, 100 mg/ml streptomycin, 4.5 mM
stimulation in the absence of virus. The viral proteins, glutamine, 20g/ml ECGF, and 50g/ml heparin. Cells were washed
either in Wash medium (RPMI 1640 and 2% heat inactivated FCS)however, responsible for nondeletional T cell suppres-
or WashE medium (RPMI 1640, 5% heat inactivated FCS, 10mMsion remain to be defined. In addition to viral molecules,
HEPES, and 2mM EDTA). Recombinant GM-CSF, IL4, M-CSF, TNF-,apoptotic T cells themselves may contribute to suppres-
and IFN- were all purchased from R&D Systems. Monocyte-con-sion of surviving T lymphocytes by releasing immuno-
ditioned medium (MCM) was generated as described by others
suppressive cytokines (Chen et al., 2001). (Bender et al., 1996).
On the basis of our findings, we propose that the
infection of mature DC allows HCMV to evade T cell
Cells
attack by a multilayered strategy (Figure 7). As a first Buffy coats were supplied by the blood bank of the University of
layer of defense, HCMV blocks antigen presentation Heidelberg or the Red Cross of Berlin. Peripheral blood mononuclear
cells (PBMC) were isolated by centrifugation over ficoll-paqueand, hence, initiation of an efficient antiviral immune
(Amersham Pharmacia Biotech). In addition, we isolated PBMC fromresponse by a variety of distinct mechanisms, resulting
three immunosuppressed patients after organ transplantationin partial MHC downregulation. However, this strategy
(heart, kidney) at the University of Heidelberg. The patients showedis not failsafe. Some MHC-peptide complexes sneak
active HCMV infection as defined by detection of HCMV-DNA and
through this layer of viral defense. Even weakly reactive pp65 in leukocytes (more than 100 pp65-positive cells in 5  105
T cells may be activated by HCMV-infected DC because leukocytes). Monocytes were isolated from PBMC by plastic adhe-
sion for 1 hr at 37C, contaminating cells being removed by fourof their strong costimulatory capacity. As a further layer
washes. The resultant cells consisted of 75% CD14, and afterof defense, HCMV-infected mature DC suppress prolif-
collection by scraping, were then centrifuged over a 14.5% metri-eration of activated T cells by deletional (via CD95L and
zamide gradient to further purify undamaged monocytes. A finalTRAIL) and nondeletional mechanisms. Further investiga-
stage of negative selection was then performed using murine anti-
tion of these mechanisms will help to understand and bodies against human TCR, CD19, and CD56, followed by goat
possibly prevent the immunosuppressive and immuno- anti-mouse-coated magnetic particles (Dynal, Hamburg) and three
rounds of magnetic selection. We generated macrophages by treat-pathological conditions associated with HCMV infection.
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ment of monocytes with M-CSF and TNF-. Multinuclear giant cells many). Digitized images were stored for each fluorochrome and then
overlayed electronically for evaluation of two-color experiments.were obtained after treatment of monocytes with GM-CSF and IFN-.
In order to generate immature DC, monocytes were cultivated in
RP medium with GM-CSF and IL-4 both at 1000 U/ml for 7 days, Detection of Intracellular IFN-
one half of the medium being changed every 3 days. At day 7, Uninfected or HCMV-infected mature DC from seronegative or sero-
nonadherent cells were removed and recultivated with 33% MCM positive donors were mixed with autologous lymphocytes at a ratio
for 3 days to generate mature DC. In certain experiments, TNF- of 1:40 and incubated for 6 hr. For the last 4 hr monensin was added.
1000 U/ml, TNF- 1000 U/ml with 33% MCM, or LPS 1 g/ml were The cells were then stained with anti-CD8 labeled with Cy-Chrome
used as the maturation signals. Cells isolated by this method were before being fixed and permeabilized with the cytoperm kit (all sup-
98% mature dendritic cells as determined by CD83 and other plied by Pharmingen, Hamburg, Germany). Cells were then stained
surface molecules (data not shown). HEL cells purchased from Serva with FITC-labeled IFN- (R&D Systems, Minneapolis) before being
were used between passages 10 and 25 for titration of virus by the measured by flow cytometry
plaque-dilution method. Cultures with human umbilical vein endo-
thelial cells (HUVEC) prepared by the method of Jaffe et al. (Jaffe Antibodies
et al., 1973) were grown on gelatin-coated plates and used between The following antibodies have been used for phenotypic analysis
passages 2 and 5. of cell markers by flow cytometry: anti-HLA-DR, DP, DQ (clone
TU¨39), anti-CD83 (clone HB15e), anti-CD86 (clone IT2.2), anti-CD95L
(clone NOK-1), anti-CD54 (clone HA58), anti-CD4 (clone RPA-T4),
Viruses and Infection anti-CD8 (clone HIT8a), anti-CD11b (clone ICRF44), anti-CD14 (clone
The HCMV isolates NEWT and MOLD have been propagated in M5E2), anti -CD19 (clone HIB19), anti-CD25 (clone M-A251), anti -CD40
HUVEC and were used for the majority of the experiments. Certain (clone LOB7/6), anti -CD56 (clone B159), and anti-CD58 (clone
experiments were repeated with freshly isolated HCMV strains. Virus L306.4) and were purchased from PharMingen; anti-CD1a (clone
was prepared by inoculation of 10,000–50,000 pfu on confluent cul- NA1/34), anti-TCR (clone BMA 031), and anti-MHC I (clone W6/32)
tures of HUVEC in 175 ml cell culture flasks. Cells were maintained were obtained from Serotec; anti-CD55 (Clone BRIC 110) was bought
for 7–14 days when 15%–50% of the cells showed lysis. Supernatant from Southern Biotechnology; CD44 (Clone F10-44-2) was pur-
was then collected daily and centrifuged at 4,000 rpm for 10 min chased from Cymbus Biotechnology; CD80 (Clone MAB104) was
(4C). The resulting supernatant was frozen at 	70C. When suffi- obtained from Immunotech; for detection of the membrane form of
cient viral supernatant was collected, the supernatants were thawed TNF-, clone 6401 from R&D systems was used. For detection of
and centrifuged at 100,000  g for 1 hr (4C). The resultant viral viral proteins in immunochemistry, FACS-analysis, and confocal mi-
pellet was carefully dried and resuspended in RP medium. Aliquots croscopy, the following antibodies have been employed: anti-IE
were then frozen on liquid nitrogen. Before use, an aliquot was (clone E13) was obtained from Argene; anti-IE (clone NEN9221) was
thawed and tested for mycoplasma (Mycoplasma ELISA, Boehringer provided by Dupont; anti-pp65 (clone O83) was purchased from
Mannheim, Germany) and endotoxins (Limulus Amebocyte Test, DUNN Labortechnik, and anti-p22 (cloneBM219) was provided by
Sigma, Germany). The viral titer was determined by the endpoint- SANBIO. Labeled secondary antibodies and streptavidin-linked flu-
dilution method. Before infection, cells were washed once in Wash orochromes were obtained from Southern Biotechnology.
medium and resuspended in RP medium. DC were then incubated
either with live virus or with heat inactivated virus (30 min at 56C)
Apoptosis Blocking and Inducing Reagentsat a MOI of 5. The latter procedure was termed mock infection.
Chimeric proteins consisting of the extracellular portion of humanThereafter, DC were washed once with WashE and twice with Wash
CD95, human TRAIL-R2, and human TNF-R2 combined with the Fcmedium before resuspension in RP medium supplemented with
portion of human IgG were produced by transient transfection ofGM-CSF (400 U/ml), IL-4 (400 U/ml), and either 33% MCM or TNF-
COS7 cells with expression plasmids encoding the various proteins(500 U/ml) and cultivated with regular changes in medium for up to
in pcDNA3.1 (Invitrogen, Groningen, Netherlands), and the subse-14 days. For the determination of virus production, 1/6 vol medium
quent purification was on Protein G-Sepharose columns (Amershamwas replaced daily, and the used supernatant was centrifuged and
Pharmacia Biotech). The agonistic anti-CD95 antibody (clone DX2)frozen at 	70C. Virus titer was estimated by the plaque-dilution
was purchased from PharMingen. Recombinant TRAIL was pro-method within 3 weeks of freezing.
duced as described (Walczak et al., 1997).
Mixed Lymphocyte ReactionFlow Cytometry, Immunochemistry, and Confocal
Mature dendritic cells either infected with HCMV for 5 days or incu-Laser Scanning Microscopy
bated with heat inactivated HCMV (mock infected) were irradiatedFor surface immunofluorescence by flow cytometry, cells in suspen-
(8,000 rad). Different numbers of these cells were mixed with 105sion were washed once with ice-cold FACSwash solution (PBS with
allogeneic T cells per well in a 96-well plate. T cells were purified1% BSA and 0.05% sodium azide) before being resuspended with
by depletion of monocytes from PBMC by plastic adherence for 1 hrthe first antibody in ice-cold blocking solution (PBS with 10% heat
at 37C and subsequent depletion of B cells by incubation with goatinactivated FCS, 1% heat-inactivated human AB serum, and 0.2%
anti-human IgG-coated paramagnetic beads 15 min at 4C (Dynal,sodium azide) for 45 min. The cells were then washed in ice-cold
Germany). Mixed lymphocyte reactions were incubated for 1–5 daysFACSwash solution and the staining repeated with FITC-coupled
before addition of [3H]thymidine for 18 hr at 37C. Thereafter, labeledgoat anti-mouse secondary antibody. After the final staining step,
cells were harvested and counted.the cells were washed in ice-cold FACSwash and then resuspended
in 200 ml PBS with 0.2% formaldehyde. Double stainings with detec-
tion of intranuclear viral IE-proteins were done essentially as de- JAM Assay
For quantification of cell death, the JAM assay (Matzinger, 1991)scribed (Dengler et al., 2000). Flow cytometry was performed on a
FACScan (Becton Dickinson, Heidelberg, Germany) linked to an was employed. In this assay, target cells are labeled with tritiated
thymidine. If the labeled cell population becomes apoptotic, theApple Macintosh Quadra 650 using CELLQuest software for data
analysis. For immunohistochemistry, cells were initially fixed with fragmented DNA will be washed through glass fiber filters during
harvesting. In the absence of cell death, DNA remains intact and4% PFA in PBS for 10 min at 4C, washed three times in PBS, and
then permeabilised with 0.1% Triton X-100 in PBS for 5 min. After will be captured by the filters. The percentage of apoptosis can be
calculated by comparing the amount of filter-bound [3H]thymidinethree final PBS washes, the cells were incubated for 15 min at 37C
with blocking solution before monoclonal antibodies were added. in the presence and absence of the cell death-inducing event. To
this end, proliferating target cells were pulsed overnight with tritiatedStaining was otherwise as for flow cytometry except that slides
were incubated at 37C and that isotype-specific secondary anti- thymidine at a concentration of 5 Ci/ml (New England Nuclear).
Cellular debris was removed by ficoll-paque purification, the cellsbodies were used. Latex beads for detection of phagocytic activity
were provided by SIGMA. Digitized images were generated using a washed three times with wash medium, and counted before being
used as target cells. The target cells were then incubated for 7 hr atconfocal laser scanning microscope (LSM 10, Zeiss, Oberkochen, Ger-
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a density of 105 cells in round-bottomed 96-well plates with different Alcami, A., and Koszinowski, U.H. (2000). Viral mechanisms of im-
mune evasion. Immunol. Today 21, 447–455.numbers of effector cells before being harvested and counted. When
present, blocking reagents were added to target cells before the Ashkenazi, A., Pai, R.C., Fong, S., Leung, S., Lawrence, D.A., Mar-
admixture of effector cells at a concentration of 10 g/ml. All mea- sters, S.A., Blackie, C., Chang, L., McMurtrey, A.E., Hebert, A., et
surements given represent the mean of three wells, and all experi- al. (1999). Safety and antitumor activity of recombinant soluble Apo2
ments were replicated at least three times on separate occasions. ligand. J. Clin. Invest. 104, 155–162.
Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and the
Three Day Apoptosis Assays control of immunity. Nature 392, 245–252.
The 7.5 104 mature DC were mixed with 4 106 syngeneic lympho-
Bender, A., Sapp, M., Schuler, G., Steinman, R.M., and Bhardwaj,cytes in 2 ml medium. Blocking reagents were added at a concentra-
N. (1996). Improved methods for the generation of dendritic cellstion of 15 g/ml. After an incubation period of 3 days, the cells were
from nonproliferating progenitors in human blood. J. Immunol. Meth-harvested and used to analyze activation and apoptosis. Activation
ods 196, 121–135.of T lymphocytes was determined by cytofluorimetric analysis of
Bertho, N., Drenou, B., Laupeze, B., Berre, C.L., Amiot, L., Grosset,cells stained for CD3 and either CD25 or CD69. Apoptosis was
J.M., Fardel, O., Charron, D., Mooney, N., and Fauchet, R. (2000).detected by two separate assays. The degree of apoptosis and
HLA-DR-mediated apoptosis susceptibility discriminates differenti-necrosis was determined by a combination of annexin staining and
ation stages of dendritic/monocytic APC. J. Immunol. 164, 2379–propidium iodide exclusion assay (Boehringer Mannheim). In addi-
2385.tion, apoptosis was also quantified by analyzing the DNA content
of cells using the propidium iodide inclusion assay (Nicoletti et al., Bhardwaj, N. (1997). Interactions of viruses with dendritic cells: a
1991). In this assay, cells were stained initially for CD3 before being double-edged sword. J. Exp. Med. 186, 795–799.
fixed with 4% paraformaldehyde for 10 min. Cells were then washed Bhardwaj, N., Young, J.W., Nisanian, A.J., Baggers, J., and
with PBS and incubated with saponin 0.1%/RNase A (50 U/ml) for Steinman, R.M. (1993). Small amounts of superantigen, when pre-
30 min before being washed and finally resuspended in PBS con- sented on dendritic cells, are sufficient to initiate T cell responses.
taining 5 g/ml propidium iodide. In this assay, apoptotic cells show J. Exp. Med. 178, 633–642.
as a subdiploid peak.
Bhardwaj, N., Bender, A., Gonzalez, N., Bui, L.K., Garrett, M.C.,
and Steinman, R.M. (1994). Influenza virus-infected dendritic cells
Generation of HCMV-Reactive T Cells
stimulate strong proliferative and cytolytic responses from human
PBMC from HCMV-seropositive donors were incubated with UV-
CD8 T cells. J. Clin. Invest. 94, 797–807.
inactivated HCMV virions at a MOI of 0.1 for 7 days. Surviving cells
Blauvelt, A., Clerici, M., Lucey, D.R., Steinberg, S.M., Yarchoan, R.,were separated by ficoll purification, and CD8 and CD4 cells
Walker, R., Shearer, G.M., and Katz, S.I. (1995). Functional studieswere then selected by biotinylated primary antibodies followed by
of epidermal Langerhans cells and blood monocytes in HIV-infectedstrepavidin-coated MACS beads (Miltenyi Biotec, Bergisch Glad-
persons. J. Immunol. 154, 3506–3515.bach, Germany). Cells were then expanded for a further 8 days with
Britt, W.J., and Alford, C.A. (1996). Cytomegalovirus. In Virology. B.N.RPMI-hu medium containing 25 U/ml human IL-2 and irradiated
Fields, D.M. Knipe, and P.M. Howley, eds. (Philadelphia: Lippincott-autologous PBMC previously loaded with UV-inactivated HCMV viri-
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(1997). Inflammatory stimuli induce accumulation of MHC class II
Detection of Nondeletional T Cell Suppression complexes on dendritic cells. Nature 388, 782–787.
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